Literature DB >> 11390719

Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and pro-inflammatory cytokines.

C H Bolton1, L G Downs, J G Victory, J F Dwight, C R Tomson, M I Mackness, J H Pinkney.   

Abstract

BACKGROUND: Chronic renal failure (CRF) is associated with an increased risk of ischaemic heart disease (IHD), but the mechanisms responsible are controversial. We investigated the relationship of two sets of candidate mechanisms-indices of LDL oxidation and markers of inflammatory activity-with vascular endothelial dysfunction (VED).
METHODS: We carried out cross-sectional analysis of 23 dialysed and 16 non-dialysed CRF patients, 28 healthy controls, and 20 patients with stable angina and normal renal function. The following were determined: (i) LDL oxidation by Cu(2+) and ultraviolet light, serum autoantibodies to oxidized LDL (oxLDL); (ii) forearm flow-mediated vasodilatation, plasma concentrations of adhesion molecules, and von Willebrand factor (vWF); and (iii) circulating levels of TNF-alpha and IL-6, C-reactive protein (CRP), and fibrinogen.
RESULTS: Endothelium-dependent vasodilatation (EDV) was lower in angina, pre-dialysis, and dialysis CRF patients than in controls (all P<0.005). Compared with controls, vWf (P<0.005) and adhesion molecules (vCAM-1, P<0.005; iCAM-1, P=0.01; E-selectin, P=0.05) were raised in dialysis, and vCAM-1 (P=0.01) in pre-dialysis CRF patients. Dialysed patients had lower HDL cholesterol (P=0.01) and higher triglyceride (P=0.05) than controls, but LDL-oxidation was similar in all groups. Autoantibodies to oxLDL were raised in angina (P<0.005) and pre-dialysis (P=0.006), but were absent in most dialysed patients. Concentrations of IL-6, TNF-alpha, CRP and fibrinogen were elevated in CRF compared with control and angina patients (P<0.005). In the whole population, IL-6 and TNF-alpha correlated negatively with EDV, HDL cholesterol, and positively with triglyceride, blood pressure, vWf, iCAM-1, vCAM-1 and E-selectin (r=-0.43 to +0.70, all P<0.05).
CONCLUSIONS: Endothelial dysfunction is unrelated to LDL oxidation, suggesting that LDL oxidation might not be a major cause of VED in CRF. In contrast VED was more severe in CRF than in angina patients and is associated with increased acute-phase proteins and plasma cytokines, demonstrating a chronic inflammatory state. These observations may explain the VED and increased IHD risk of patients with CRF.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390719     DOI: 10.1093/ndt/16.6.1189

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  59 in total

1.  Report of an NIH task force on research priorities in chronic kidney disease in children.

Authors:  Russell W Chesney; Eileen Brewer; Marva Moxey-Mims; Sandra Watkins; Susan L Furth; William E Harmon; Richard N Fine; Ronald J Portman; Bradley A Warady; Isidro B Salusky; Craig B Langman; Debbie Gipson; Peter Scheidt; Harold Feldman; Frederick J Kaskel; Norman J Siegel
Journal:  Pediatr Nephrol       Date:  2005-10-27       Impact factor: 3.714

2.  Indoxyl sulfate-induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.

Authors:  Mina Yu; Young Ju Kim; Duk-Hee Kang
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-28       Impact factor: 8.237

Review 3.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

4.  Altered Expression Pattern of CD55 and CD59 on Red Blood Cells in Anemia of Chronic Kidney Disease.

Authors:  Lama Al-Faris; Salah Al-Humood; Fatma Behbehani; Husam Sallam
Journal:  Med Princ Pract       Date:  2017-09-28       Impact factor: 1.927

5.  Vascular endothelial function and blood pressure regulation in afferent autonomic failure.

Authors:  Qurat-Ul-Ain Jelani; Lucy Norcliffe-Kaufmann; Horacio Kaufmann; Stuart D Katz
Journal:  Am J Hypertens       Date:  2014-08-15       Impact factor: 2.689

6.  Inflammation, vitamin D and dendritic cell precursors in chronic kidney disease.

Authors:  K Paul; S Franke; J Nadal; M Schmid; A Yilmaz; D Kretzschmar; B Bärthlein; S Titze; A Koettgen; G Wolf; M Busch
Journal:  Clin Exp Immunol       Date:  2016-08-16       Impact factor: 4.330

7.  Aortic PWV in chronic kidney disease: a CRIC ancillary study.

Authors:  Raymond R Townsend; Neil J Wimmer; Julio A Chirinos; Afshin Parsa; Matthew Weir; Kalyani Perumal; James P Lash; Jing Chen; Susan P Steigerwalt; John Flack; Alan S Go; Mohammed Rafey; Mahboob Rahman; Angela Sheridan; Crystal A Gadegbeku; Nancy A Robinson; Marshall Joffe
Journal:  Am J Hypertens       Date:  2009-12-17       Impact factor: 2.689

Review 8.  Inflammation regulates fibroblast growth factor 23 production.

Authors:  Connor Francis; Valentin David
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-07       Impact factor: 2.894

9.  Tumor necrosis factor (TNF-alpha) and C-reactive protein (CRP) are positively associated with the risk of chronic kidney disease in patients with type 2 diabetes.

Authors:  Eun-Sil Yeo; Ji-Yun Hwang; Ji Eun Park; Young Ju Choi; Kap Bum Huh; Wha Young Kim
Journal:  Yonsei Med J       Date:  2010-07       Impact factor: 2.759

Review 10.  Advances and new frontiers in the pathophysiology of venous neointimal hyperplasia and dialysis access stenosis.

Authors:  Timmy Lee; Prabir Roy-Chaudhury
Journal:  Adv Chronic Kidney Dis       Date:  2009-09       Impact factor: 3.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.